74 completed, 21 unknown, 16 terminated, 14 withdrawn. 33 Phase 2, 23 Not applicable, 13 Phase 3, 8 Phase 1, 1 Early Phase 1.
Follow SARS-CoV 2: new trials by email Literature Review of SARS-CoV 2 trials Research Report on SARS-CoV 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease Kisspeptin 112-121 - Reproductive Disorder, Neurodegeneration | Phase 1 | Recruiting | Stephanie B. Seminara, MD | 40 | 2026-03-10 | 2026-07-13 |
| Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease Lactoferrin (Apolactoferrin), Placebo of excipient(s) will be administered - Corona Virus Infection, Middle East Respiratory Syndrome (MERS) | Phase 2 | Unknown | National Research Centre, Egypt | 516 | 2022-02-01 | 2021-11-15 |
| The Effects of a Music Therapy Respiratory Protocol on Post-Covid-19 Respiratory Symptoms Respiratory Music Therapy Protocol - Post Covid-19 Respiratory, Dyspnea | Not applicable | Completed | Icahn School of Medicine at Mount Sinai | 33 | 2022-01-13 | 2024-02-14 |
| Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo - SARS-CoV 2, COVID | Phase 3 | Withdrawn | APR Applied Pharma Research s.a. | 2021-12-15 | 2026-05-14 | |
| Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer COVID, SARS-CoV 2 | Unknown | Centre Hospitalier le Mans | 2000 | 2021-12-01 | 2022-07-28 | |
| Characteristics of Patients With COVID-19 in Meta State, Colombia COVID, SARS-CoV 2 | Withdrawn | Hospital Departamental de Villavicencio | 2021-09-01 | 2023-07-05 | ||
| Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19 5-ALA-Phosphate + SFC (5-ALA+SFC) - SARS-COV 2, Covid19 | Not applicable | Withdrawn | Royal College of Surgeons in Ireland - Medical University of Bahrain | 2021-08-15 | 2021-09-22 | |
| Emergency Department (ED) Self-Monitoring Pilot COVID-19 Symptoms entered into the CovidX application - COVID, Covid-19 | Not applicable | Withdrawn | University of Michigan | 2021-06-01 | 2021-07-01 | |
| Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations SARS-CoV2 antibody measurement - SARS-CoV 2 | Active not recruiting | Karolinska Institutet | 10000 | 2021-04-01 | 2025-03-20 | |
| Trial to Promote Recovery From COVID-19 With Endocrine Therapy Bicalutamide 150 Mg Oral Tablet - COVID-19, SARS-CoV 2 | Phase 2 | Withdrawn | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-04-01 | 2021-03-05 | |
| Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) Oral-B Mouth Sore mouthwash, Crest Pro-Health Multi-Protection mouthwash, CloSYS Ultra Sensitive Rinse mouthwash - COVID-19, SARS-CoV 2 | Phase 2 | Terminated | University of California, San Francisco | 54 | 2021-03-31 | 2023-11-18 |
| Convalescent Plasma for Early Treatment of COVID-19 Convalescent Plasma (anti-SARS-CoV-2 plasma), Control (albumin 5%) - SARS-CoV 2, COVID-19 | Phase 2 | Terminated | Andrew Eisenberger | 223 | 2021-03-12 | 2024-08-28 |
| Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients SARS-CoV 2, Hospitalisation-Associated Infection | Completed | Elsan | 200 | 2021-03-10 | 2022-10-19 | |
| Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo - SARS-CoV 2, COVID | Phase 2 / Phase 3 | Terminated | APR Applied Pharma Research s.a. | 144 | 2021-02-15 | 2023-02-03 |
| Fase I Clinical Trial on NK Cells for COVID-19 Natural Killer Cells infusion - Covid19, Sars-cov 2 | Phase 1 | Unknown | Hospital de Clinicas de Porto Alegre | 24 | 2021-01-02 | 2020-11-18 |
| Carrageenan Nasal Spray for COVID-19 Prophylaxis Carrageenan nasal and throat spray, Saline nasal and throat spray - COVID-19, SARS-CoV 2 | Not applicable | Completed | Swansea University | 480 | 2020-12-17 | 2023-04-28 |
| Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling COVID-19, SARS-CoV 2 | Completed | Duke University | 602 | 2020-12-11 | 2024-06-06 | |
| Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19 5-ALA-Phosphate + SFC (5-ALA + SFC) - SARS-CoV 2, COVID-19 | Not applicable | Completed | Royal College of Surgeons in Ireland - Medical University of Bahrain | 15 | 2020-11-15 | 2022-02-09 |
| Anti-SARS Cov-2 T Cell Infusions for COVID 19 Dose Finding Phase (MTD), Partially HLA-matched SARS-CoVSTs, Routine care (no SARS-CoVSTs) - SARS-CoV 2, Viral Infection | Phase 1 | Terminated | Baylor College of Medicine | 4 | 2020-11-04 | 2022-12-19 |
| WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories Equipment with smartwatch throughout hospital stay on the general ward - COVID, COVID 19 | Completed | Insel Gruppe AG, University Hospital Bern | 46 | 2020-10-22 | 2021-08-26 |
Showing 20 of 132. Sign in to see all of them.
COVID-19 (90) · Coronavirus Infections (44) · Severe Acute Respiratory Syndrome (8) · Respiratory Distress Syndrome (6) · Pneumonia (5) · Pneumonia, Viral (5) · Virus Diseases (5) · Dyspnea (4) · Cytokine Release Syndrome (3) · Acute Lung Injury (2) · Cross Infection (2) · Disease (2) · Infections (2) · Respiration Disorders (2) · Respiratory Insufficiency (2)
Infections (104) · Coronaviridae Infections (103) · Nidovirales Infections (103) · RNA Virus Infections (103) · Respiratory Tract Diseases (101) · Virus Diseases (99) · Lung Diseases (98) · Respiratory Tract Infections (95) · Pneumonia (89) · Pneumonia, Viral (88) · Coronavirus Infections (59) · Pathological Conditions, Signs and Symptoms (19) · Pathologic Processes (12) · Respiration Disorders (10) · Disease Attributes (7)
Hydroxychloroquine (9) · Azithromycin (4) · Blood Specimen Collection (4) · COVID-19 Serotherapy (4) · Standard of Care (4) · Sodium Glutamate (2) · aviptadil (2) · mavrilimumab (2) · Arthroplasty, Replacement, Hip (1) · BCG Vaccine (1) · Blinking (1) · Buffers (1) · COVID-19 Serological Testing (1) · Calcifediol (1) · Cetylpyridinium (1)
Royal College of Surgeons in Ireland - Medical University of Bahrain (4) · University Hospital, Lille (4) · APR Applied Pharma Research s.a. (2) · Assistance Publique - Hôpitaux de Paris (2) · Azienda Ospedaliero, Universitaria Pisana (2) · Beyond Air Inc. (2) · Dr. Alexander Supady (2) · Hospital Italiano de Buenos Aires (2) · Hospital de Clinicas José de San Martín (2) · Maimónides Biomedical Research Institute of Córdoba (2) · The Cleveland Clinic (2) · University of Cologne (2) · University of Colorado, Denver (2) · University of Missouri-Columbia (2) · University of Sao Paulo General Hospital (2)
United States (38) · France (16) · Spain (12) · Brazil (10) · Italy (8) · United Kingdom (8) · Germany (6) · Canada (4) · Switzerland (4) · Argentina (3) · Austria (3) · Bahrain (3) · Sweden (3) · Belgium (2) · Mexico (2)
Jonathan C Javitt, MD, MPH (2) · Manaf Al Qahtani, Dr. (2) · Paul C Cremer, M. D. (2) · Abdulla Darwish, Dr (1) · Abdullah Darwish, Dr (1) · Adam Schrum, PhD (1) · Alberto M Borobia, MD, PhD (1) · Alexander R Precioso, MD, PhD (1) · Alexander Supady, Dr., MPH (1) · Alexander Supady, MD, MPH (1) · Alexandra E Kejner, MD (1) · Antoni Torres, MD, PhD (1) · Antonio J Carcas (1)
PMID 32150360, PMID 32219428, PMID 33754144, PMID 11023960, PMID 20370679, PMID 22588759, PMID 23666438, PMID 25457751, PMID 31565258, PMID 31668196, PMID 31995857, PMID 32031583, PMID 32032529, PMID 32083643, PMID 32091533, PMID 32125452, PMID 32146445, PMID 32146694, PMID 32171076, PMID 32178769, PMID 32183930, PMID 32187459, PMID 32198501, PMID 32199474, PMID 32219885, PMID 32220207, PMID 32220208, PMID 32221519, PMID 32221523, PMID 32227758, PMID 32228825, PMID 32237190, PMID 32240128, PMID 32251638, PMID 32266381, PMID 32283245, PMID 32301221, PMID 32303365, PMID 32333494, PMID 32650818, PMID 32876113, PMID 32936949, PMID 33085857, PMID 33191263, PMID 33273742, PMID 33455938, PMID 33521775, PMID 33580261, PMID 33604400, PMID 33627609
R01AI152078 (1), R37HD043341 (1), U24TR001609 (1), UL1TR003098 (1)